On June 10, 2025, Xilio Therapeutics, Inc. expanded its Board of Directors to ten members, electing Akintunde Bello, Ph.D., who will serve until the 2026 annual meeting and join the Nominating and Corporate Governance Committee. Compensation details for Dr. Bello are in line with the company's standard arrangements for directors.